BI 2536 Uses, Dosage, Side Effects and more

BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer).

Trade Name BI 2536
Generic BI 2536
Type
Formula C28H39N7O3
Weight Average: 521.666
Monoisotopic: 521.311438144
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share